We are now accepting abstract submissions from those wishing to speak at Extractables and Leachables Asia 2025, taking place this June in Singapore.

If you would like to speak on any of the below themes or another topic related to E&L, we'd like to hear from you:

• Case study on Extractables and Leachables (E&L) in pharmaceuticals, biologics , medical devices and combination products
• Perspectives and practices from companies of pharma, bio-tech, medical devices etc.
• Challenges and approaches of E&L study in SUS and SUP
• Practical issues associated with E&L testing
• E&L regulations and standards: FDA, EU MDR and more
• Update on ICH Q3E guidelines
• Update on USP <1664>
• Characterization and evaluation of medical devices
• Biological evaluation strategies
• Risk assessment of components used in Single-Use Production
• Toxicological risk assessment for absorbable medical devices
• Detection of biological toxic substances
• Biological evaluation and biocompatibility assessment
• Testing of biodegradable medical devices
• Identification of unknown extractables
• Emerging topics, research developments, and technological advances in E&L studies

Deadline for submissions: Friday 28^th Feb 2025

Please submit your abstract via the form below. 

Should you have any questions, please contact the conference producer Nancy Yao at nyao@smithers.com or on +86 180 5109 2296.